[1] |
ZHANG Shujing, SUN Lixin, CAO Yuqing.
Comparative Study on the Clinicopathological Features and Prognostic between HPV-related and Non-HPV-related Cervical Adenocarcinoma
[J]. Chinese General Practice, 2025, 28(14): 1758-1764.
|
[2] |
YUAN Xiaorui, TAN Yanlin, FU Chun.
Construction of the Predictive Model for Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer: Based on 18F-FDG PET/CT Radiomics Technology
[J]. Chinese General Practice, 2025, 28(12): 1465-1472.
|
[3] |
ZHANG Yushuang, WU Zhongbing, HUANG Ming, JIA Lei, GAO Shuang, ZHAO Weipeng, LI Jing.
Study on Metabolic Characteristics in Esophageal Squamous Cell Carcinoma Patients with TCM Differentiation of Deficiency of Fluid and Blood Based on Non Target Metabolomics
[J]. Chinese General Practice, 2025, 28(12): 1513-1519.
|
[4] |
LOU Xianzhe, MIAO Tongguo, ZHANG Shiya, MA Dong, NAN Yuemin.
The Impact of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio on the Prognosis of Patients with Non-Viral, Non-Alcoholic Hepatocellular Carcinoma: a Retrospective Cohort Study
[J]. Chinese General Practice, 2025, 28(09): 1092-1099.
|
[5] |
MA Xiaoxuan, WANG Rongqi.
Research Progress in Metabolomics for HCC Diagnosis and Treatment
[J]. Chinese General Practice, 2025, 28(08): 1017-1022.
|
[6] |
SONG Fenfen, LI Shengmian.
Real-World Study of Camrelizumab-based Regimen for Locally Advanced and Metastatic Esophageal Cancer
[J]. Chinese General Practice, 2025, 28(07): 844-852.
|
[7] |
ZHANG Jin, SUN Di, WANG Hao, SHI Cong, ZHAO Yihan, PAN Yijin, MU Zhuanzhuan, DING Zhiguo, LIN Yansong.
Factors Influencing Biochemical Progression in Distant Metastatic Papillary Thyroid Carcinoma
[J]. Chinese General Practice, 2024, 27(36): 4546-4553.
|
[8] |
YANG Anyin, LIU Hongli, CHEN Miaoyang, ZHENG Yufeng, XU Zhiyuan, YANG Yongfeng.
Mechanism and in Vitro Experiment of Wogonin in Treatment of Hepatocellular Carcinoma Based on Network Pharmacology
[J]. Chinese General Practice, 2024, 27(32): 4040-4049.
|
[9] |
CHEN Chao, CHEN Tianxiang, LIU Qianwei, ZHANG Zhi, WANG Huanhuan, WU Pingping, GAO Lei, YU Zhaoxiang.
Analysis and Identification of Hub Genes in Hepatocellular Carcinoma Based on Weighted Gene Co-expression Network and Cancer Genome Atlas Clinical Data
[J]. Chinese General Practice, 2024, 27(32): 4050-4059.
|
[10] |
MAIERHABA· Maimaitiaili, ZHANG Kainan, ZHAO Hui, YAKUFU· Tuoheti, YE Jianwei, LYU Guodong.
Investigating Serum PARP2 as a Potential Diagnostic Biomarker for Hepatocellular Carcinoma
[J]. Chinese General Practice, 2024, 27(32): 4060-4065.
|
[11] |
HU Lingxi, LI Mei, FU Yiwei, LU Lixia, MA Xiaoxuan, WANG Rongqi, NAN Yuemin.
The Value of Serum VEGF in Evaluating the Clinical Efficacy of TACE Alone or Combined with Target Immunotherapy in Advanced Hepatocellular Carcinoma
[J]. Chinese General Practice, 2024, 27(32): 4033-4039.
|
[12] |
LIN Xinrong, JIA Lei, LI Lifeng, HUANG Ming, WU Zhongbing, LI Jing.
Study on the Inhibition of Esophageal Carcinoma Development in Mice by Salvia Chinensia Benth Induced Ferroptosis
[J]. Chinese General Practice, 2024, 27(30): 3784-3789.
|
[13] |
LI Zhiyong, LI Guohua, HUANG Pengfei, ZHANG Yunjing, LOU Xianzhe, ZHAO Junjian.
Association of Peripheral Blood Mononuclear Cell to HDL Cholesterol Ratio with Papillary Thyroid Carcinoma in Different Genders
[J]. Chinese General Practice, 2024, 27(25): 3159-3163.
|
[14] |
ZHANG Yun, CAI Xinyi, DING Jingnuo, LU Shengwei, CHEN Cuiying, WU Tingting, ZHANG Junli, ZHAO Weifeng.
Study on the Value of Oligosaccharide Chain and Alpha-fetoprotein for Risk Screening and Diagnosis of Hepatitis B Virus-related Hepatocellular Carcinoma
[J]. Chinese General Practice, 2024, 27(15): 1855-1860.
|
[15] |
FAN Guohua, SUN Jingyun, JI Juan, XU Wenjing, ZHAO Juan.
Effect of Press-needle Therapy on Prevention of Myelosuppression after Chemotherapy of Non-small-cell Lung Cancer Patients based on the Midnight-noon Ebb-flow Point Selection Theory
[J]. Chinese General Practice, 2024, 27(06): 733-738.
|